McKesson Is Maintained at Equal-Weight by Wells Fargo
Investors in McKesson (NYSE:MCK) Have Seen Splendid Returns of 264% Over the Past Five Years
Deutsche Bank Trims Price Target on McKesson to $623 From $631
Leerink Partners Maintains McKesson(MCK.US) With Buy Rating, Maintains Target Price $665
Michael Cherny Reaffirms Buy Rating on McKesson Amid Temporary Setbacks and Long-Term Growth Prospects
Wells Fargo Maintains McKesson(MCK.US) With Hold Rating, Cuts Target Price to $535
Analysts Offer Insights on Healthcare Companies: Immuneering (IMRX), McKesson (MCK) and Neurocrine (NBIX)
McKesson (MCK) Rises Yet Lags Behind Market: Some Facts Worth Knowing
Is McKesson Stock Underperforming the S&P 500?
McKesson Corporation (MCK) Is Attracting Investor Attention: Here Is What You Should Know
McKesson Corporation's (NYSE:MCK) Institutional Investors Lost 11% Last Week but Have Benefitted From Longer-term Gains
Here's How Much You Would Have Made Owning McKesson Stock In The Last 20 Years
McKesson Analyst Ratings
Jefferies Adjusts Price Target on McKesson to $607 From $630
Citi Maintains McKesson(MCK.US) With Buy Rating, Cuts Target Price to $630
Express News | Mckesson Corp : Citigroup Cuts Target Price to $630 From $670
Biologics by McKesson's RYTELOTM, FDA Gets Approval For Treatment Of Patients With Low- To Intermediate-1 Risk Myelodysplastic Syndromes With Transfusion-Dependent Anemia
McKesson, News Corporation And 2 Other Stocks Executives Are Selling
Express News | Alithya to Co-Present With Mckesson at Oracle Cloudworld 2024
Alithya to Co-present With McKesson at Oracle CloudWorld 2024